{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T20:27:29Z","timestamp":1749328049516},"reference-count":55,"publisher":"Elsevier","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1016\/bs.irn.2017.06.002","type":"book-chapter","created":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T12:01:22Z","timestamp":1499688082000},"page":"973-986","source":"Crossref","is-referenced-by-count":5,"title":["Acute Presentation of Nonmotor Symptoms in Parkinson's Disease"],"prefix":"10.1016","author":[{"given":"Kimberly","family":"Kwei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Frucht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/bs.irn.2017.06.002_bb0010","first-page":"102","article-title":"ECT as a treatment alternative for patients with symptoms of neuroleptic malignant syndrome","volume":"48","author":"Addonizio","year":"1987","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1016\/bs.irn.2017.06.002_bb0015","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000446191","article-title":"Deep brain stimulation for status dystonicus: A case series and review of the literature","volume":"94","author":"Ben-Haim","year":"2016","journal-title":"Stereotactic and Functional Neurosurgery"},{"issue":"8","key":"10.1016\/bs.irn.2017.06.002_bb0020","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/mds.26643","article-title":"Prevalence of anxiety in Parkinson's disease: A systematic review and meta-analysis","volume":"31","author":"Broen","year":"2016","journal-title":"Movement Disorders"},{"issue":"1","key":"10.1016\/bs.irn.2017.06.002_bb0025","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0025-7125(16)30278-4","article-title":"Neuroleptic malignant syndrome","volume":"77","author":"Caroff","year":"1993","journal-title":"The Medical Clinics of North America"},{"issue":"3","key":"10.1016\/bs.irn.2017.06.002_bb0030","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1176\/ajp.146.3.324","article-title":"Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome","volume":"146","author":"Castillo","year":"1989","journal-title":"The American Journal of Psychiatry"},{"issue":"5","key":"10.1016\/bs.irn.2017.06.002_bb0035","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","article-title":"Non-motor symptoms of Parkinson's disease: Dopaminergic pathophysiology and treatment","volume":"8","author":"Chaudhuri","year":"2009","journal-title":"Lancet Neurology"},{"issue":"9222","key":"10.1016\/bs.irn.2017.06.002_bb0040","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1016\/S0140-6736(00)02410-7","article-title":"Treatment of DYT1-generalised dystonia by stimulation of the internal globus pallidus","volume":"355","author":"Coubes","year":"2000","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/bs.irn.2017.06.002_bb0045","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/mds.870130344","article-title":"Intrathecal baclofen in the treatment of dystonic storm","volume":"13","author":"Dalvi","year":"1998","journal-title":"Movement Disorders"},{"issue":"7","key":"10.1016\/bs.irn.2017.06.002_bb0050","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/mds.22833","article-title":"Anxiety disorders in Parkinson's disease: Prevalence and risk factors","volume":"25","author":"Dissanayaka","year":"2010","journal-title":"Movement Disorders"},{"issue":"4","key":"10.1016\/bs.irn.2017.06.002_bb0055","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1097\/MJT.0b013e3182456d88","article-title":"Serotonin syndrome after the use of tramadol and ziprasidone in a patient with a deep brain stimulator for Parkinson disease","volume":"21","author":"El-Okdi","year":"2014","journal-title":"American Journal of Therapeutics"},{"issue":"1","key":"10.1016\/bs.irn.2017.06.002_bb0060","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/mds.21172","article-title":"Fatal Parkinsonism-hyperpyrexia syndrome in a Parkinson's disease patient while actively treated with deep brain stimulation","volume":"22","author":"Factor","year":"2007","journal-title":"Movement Disorders"},{"issue":"6","key":"10.1016\/bs.irn.2017.06.002_bb0065","first-page":"222","article-title":"Adverse consequences of fluoxetine-MAOI combination therapy","volume":"51","author":"Feighner","year":"1990","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"19","key":"10.1016\/bs.irn.2017.06.002_bb0070","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1001\/jama.1985.03360190098033","article-title":"A neuroleptic malignantlike syndrome due to levodopa therapy withdrawal","volume":"254","author":"Friedman","year":"1985","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/bs.irn.2017.06.002_bb0075","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s13311-013-0240-3","article-title":"Treatment of movement disorder emergencies","volume":"11","author":"Frucht","year":"2014","journal-title":"Neurotherapeutics"},{"issue":"8622","key":"10.1016\/bs.irn.2017.06.002_bb0080","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(88)90852-5","article-title":"Danger of MAOI therapy after fluoxetine withdrawal","volume":"2","author":"Graham","year":"1988","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/bs.irn.2017.06.002_bb0085","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/mds.23586","article-title":"Treatment of a dystonic storm with pallidal stimulation in a patient with PANK2 mutation","volume":"26","author":"Grandas","year":"2011","journal-title":"Movement Disorders"},{"issue":"9","key":"10.1016\/bs.irn.2017.06.002_bb0090","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.4088\/JCP.10m06438","article-title":"An international consensus study of neuroleptic malignant syndrome diagnostic criteria using the Delphi method","volume":"72","author":"Gurrera","year":"2011","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"8","key":"10.1016\/bs.irn.2017.06.002_bb0095","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1176\/ajp.155.8.1113","article-title":"Novel antipsychotics and the neuroleptic malignant syndrome: A review and critique","volume":"155","author":"Hasan","year":"1998","journal-title":"The American Journal of Psychiatry"},{"issue":"12","key":"10.1016\/bs.irn.2017.06.002_bb0100","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.neurol.2016.10.002","article-title":"Combination of paroxetine and rasagiline induces serotonin syndrome in a parkinsonian patient","volume":"172","author":"H\u00e9bant","year":"2016","journal-title":"Revue Neurologique (Paris)"},{"issue":"10","key":"10.1016\/bs.irn.2017.06.002_bb0105","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1212\/WNL.32.10.1195","article-title":"Severe dystonia and myoglobinuria","volume":"32","author":"Jankovic","year":"1982","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/bs.irn.2017.06.002_bb0110","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/mds.23596","article-title":"Case report: Recurrent parkinsonism-hyperpyrexia syndrome following discontinuation of subthalamic deep brain stimulation","volume":"26","author":"Kadowaki","year":"2011","journal-title":"Movement Disorders"},{"issue":"3","key":"10.1016\/bs.irn.2017.06.002_bb0115","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/mds.20325","article-title":"Movement disorder emergencies","volume":"20","author":"Kipps","year":"2005","journal-title":"Movement Disorders"},{"issue":"Pt. 3","key":"10.1016\/bs.irn.2017.06.002_bb0120","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/brain\/121.3.451","article-title":"Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease","volume":"121","author":"Krack","year":"1998","journal-title":"Brain"},{"issue":"Suppl. 2","key":"10.1016\/bs.irn.2017.06.002_bb0125","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000113484","article-title":"Neuroleptic malignant syndrome in parkinsonian patients: Risk factors","volume":"38","author":"Kuno","year":"1997","journal-title":"European Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2017.06.002_bb0130","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00002826-198406000-00001","article-title":"Neuroleptic malignant syndrome","volume":"7","author":"Kurlan","year":"1984","journal-title":"Clinical Neuropharmacology"},{"issue":"10","key":"10.1016\/bs.irn.2017.06.002_bb0135","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1176\/ajp.142.10.1137","article-title":"Neuroleptic malignant syndrome","volume":"142","author":"Levenson","year":"1985","journal-title":"The American Journal of Psychiatry"},{"issue":"Suppl. 6","key":"10.1016\/bs.irn.2017.06.002_bb0140","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1212\/WNL.50.6_Suppl_6.S33","article-title":"Managing the neuropsychiatric symptoms of Parkinson's disease","volume":"50","author":"Lieberman","year":"1998","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2017.06.002_bb0145","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/NMD.0b013e31827ab24b","article-title":"Catatonia and neuroleptic malignant syndrome: Two disorders on a same spectrum? Four case reports","volume":"201","author":"Luchini","year":"2013","journal-title":"The Journal of Nervous and Mental Disease"},{"issue":"Pt. 2","key":"10.1016\/bs.irn.2017.06.002_bb0150","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/brain\/121.2.243","article-title":"Status dystonicus: The syndrome and its management","volume":"121","author":"Manji","year":"1998","journal-title":"Brain"},{"issue":"1","key":"10.1016\/bs.irn.2017.06.002_bb0155","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1176\/jnp.18.1.130","article-title":"Parkinson's disease following panic disorder","volume":"18","author":"Matsui","year":"2006","journal-title":"The Journal of Neuropsychiatry and Clinical Neurosciences"},{"key":"10.1016\/bs.irn.2017.06.002_bb0160","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1212\/WNL.10.12.1076","article-title":"Neurologic effects of tryptophan in patients receiving a monoamine oxidase inhibitor","volume":"10","author":"Oates","year":"1960","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/bs.irn.2017.06.002_bb0165","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/phar.1500","article-title":"Serotonin toxicity association with concomitant antidepressants and rasagiline treatment: Retrospective study (STACCATO)","volume":"34","author":"Panisset","year":"2014","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1016\/bs.irn.2017.06.002_bb0170","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1056\/NEJM199301213280305","article-title":"Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease","volume":"328","author":"Parkinson Study Group","year":"1993","journal-title":"The New England Journal of Medicine"},{"issue":"4","key":"10.1016\/bs.irn.2017.06.002_bb0175","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/mds.870040408","article-title":"\u201cOn-off\u201d-induced lethal hyperthermia","volume":"4","author":"Pfeiffer","year":"1989","journal-title":"Movement Disorders"},{"issue":"2","key":"10.1016\/bs.irn.2017.06.002_bb0180","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/jnnp-2012-302684","article-title":"Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic","volume":"84","author":"Pondal","year":"2013","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"1","key":"10.1016\/bs.irn.2017.06.002_bb0185","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/archneurol.2009.294","article-title":"Dopamine agonist withdrawal syndrome in Parkinson disease","volume":"67","author":"Rabinak","year":"2010","journal-title":"Archives of Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2017.06.002_bb0190","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1054\/mehy.2000.1047","article-title":"An exploratory approach to the serotonin syndrome: An update of clinical phenomenology and revised diagnostic criteria","volume":"55","author":"Radomski","year":"2000","journal-title":"Medical Hypotheses"},{"key":"10.1016\/bs.irn.2017.06.002_bb0195","first-page":"42","article-title":"Anxiety disorders in Parkinson's disease","volume":"96","author":"Richard","year":"2005","journal-title":"Advances in Neurology"},{"issue":"6","key":"10.1016\/bs.irn.2017.06.002_bb0200","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/archneurol.2011.117","article-title":"Movement disorders emergencies Part 2: Hyperkinetic disorders","volume":"68","author":"Robottom","year":"2011","journal-title":"Archives of Neurology"},{"issue":"5","key":"10.1016\/bs.irn.2017.06.002_bb0205","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1001\/archneurol.2011.84","article-title":"Movement disorders emergencies. Part 1: Hypokinetic disorders","volume":"68","author":"Robottom","year":"2011","journal-title":"Archives of Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2017.06.002_bb0210","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/mds.870050215","article-title":"Neuroleptic malignant syndrome treated with subcutaneous lisuride infusion","volume":"5","author":"Rodriguez","year":"1990","journal-title":"Movement Disorders"},{"issue":"3","key":"10.1016\/bs.irn.2017.06.002_bb0215","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00004714-198606000-00022","article-title":"L-dopa induced \u201cserotonin syndrome\u201d in a parkinsonian patient on bromocriptine","volume":"6","author":"Sandyk","year":"1986","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"5","key":"10.1016\/bs.irn.2017.06.002_bb0220","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/jnnp.74.5.574","article-title":"Efficacy of methylprednisolone pulse therapy on neuroleptic malignant syndrome in Parkinson's disease","volume":"74","author":"Sato","year":"2003","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"2","key":"10.1016\/bs.irn.2017.06.002_bb0225","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1212\/WNL.34.2.249","article-title":"Fatal hyperpyrexia after withdrawal of levodopa","volume":"34","author":"Sechi","year":"1984","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2017.06.002_bb0230","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1600-0447.1986.tb02694.x","article-title":"The neuroleptic malignant syndrome: Agent and host interaction","volume":"73","author":"Shalev","year":"1986","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"1","key":"10.1016\/bs.irn.2017.06.002_bb0235","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1001\/jamaneurol.2014.2472","article-title":"Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: Effects on nonmotor symptoms and tolerability","volume":"72","author":"Smith","year":"2015","journal-title":"JAMA Neurology"},{"issue":"6","key":"10.1016\/bs.irn.2017.06.002_bb0240","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1176\/ajp.148.6.705","article-title":"The serotonin syndrome","volume":"148","author":"Sternbach","year":"1991","journal-title":"The American Journal of Psychiatry"},{"issue":"1","key":"10.1016\/bs.irn.2017.06.002_bb0245","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1600-0404.1993.tb04068.x","article-title":"\u201cPanic attacks\u201d in Parkinson's disease. A long-term complication of levodopa therapy","volume":"87","author":"V\u00e1zquez","year":"1993","journal-title":"Acta Neurologica Scandinavica"},{"issue":"4","key":"10.1016\/bs.irn.2017.06.002_bb0250","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/mds.1133","article-title":"Treatment of neuroleptic malignant syndrome with subcutaneous apomorphine monotherapy","volume":"16","author":"Wang","year":"2001","journal-title":"Movement Disorders"},{"issue":"5","key":"10.1016\/bs.irn.2017.06.002_bb0255","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ajem.2005.05.001","article-title":"2004 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System","volume":"23","author":"Watson","year":"2005","journal-title":"The American Journal of Emergency Medicine"},{"issue":"5","key":"10.1016\/bs.irn.2017.06.002_bb0260","first-page":"400","article-title":"Serotonin syndrome in Parkinson disease","volume":"8","author":"Weiss","year":"1995","journal-title":"The Journal of the American Board of Family Practice"},{"issue":"5","key":"10.1016\/bs.irn.2017.06.002_bb0265","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/00004714-198109000-00002","article-title":"Combined MAOI-tricyclic antidepressant treatment: A reevaluation","volume":"1","author":"White","year":"1981","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"3","key":"10.1016\/bs.irn.2017.06.002_bb0270","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1212\/WNL.59.3.408","article-title":"Nonmotor fluctuations in Parkinson's disease: Frequent and disabling","volume":"59","author":"Witjas","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2017.06.002_bb0275","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jns.2016.12.070","article-title":"Dopamine agonist withdrawal syndrome: A comprehensive review","volume":"374","author":"Yu","year":"2017","journal-title":"Journal of the Neurological Sciences"},{"issue":"9","key":"10.1016\/bs.irn.2017.06.002_bb0280","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/mds.20510","article-title":"Stimulation of the globus pallidus internus for childhood-onset dystonia","volume":"20","author":"Zorzi","year":"2005","journal-title":"Movement Disorders"}],"container-title":["International Review of Neurobiology","Nonmotor Parkinson\u2019s: The Hidden Face - Management and the Hidden Face of Related Disorders"],"original-title":[],"link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S007477421730096X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S007477421730096X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,29]],"date-time":"2019-09-29T05:02:31Z","timestamp":1569733351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S007477421730096X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":55,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2017.06.002","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}